Yunkang Group Limited (2325.HK)
HKD 3.05
(0.0%)
HKD 3.05
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 891.5 Million CNY | -77.45% |
| 2022 | 4.36 Billion CNY | 113.6% |
| 2021 | 2.04 Billion CNY | 51.61% |
| 2020 | 1.34 Billion CNY | 75.49% |
| 2019 | 768.59 Million HKD | 8.82% |
| 2018 | 706.29 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 205.88 Million HKD | -7.93% |
| 2024 Q2 | 204.12 Million HKD | -0.15% |
| 2023 Q2 | 257.5 Million HKD | -5.52% |
| 2023 Q3 | 222.35 Million HKD | -13.65% |
| 2023 FY | 985.1 Million CNY | -77.45% |
| 2023 Q4 | 228.07 Million HKD | 2.57% |
| 2023 Q1 | 272.53 Million HKD | -79.74% |
| 2022 Q3 | 1.31 Billion HKD | -21.22% |
| 2022 FY | 4.36 Billion CNY | 113.6% |
| 2022 Q4 | 1.34 Billion HKD | 2.58% |
| 2022 Q2 | 1.66 Billion HKD | 0.0% |
| 2021 FY | 2.04 Billion CNY | 51.61% |
| 2020 FY | 1.34 Billion CNY | 75.49% |
| 2019 FY | 768.59 Million HKD | 8.82% |
| 2018 FY | 706.29 Million HKD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Life Healthcare Group Limited | 233.68 Million HKD | -281.503% |
| China Biotech Services Holdings Limited | 211.98 Million HKD | -320.549% |